[Status and progress of simultaneous liver metastasis in colorectal cancer].

Liver metastasis is one of the main causes of death in patients with colorectal cancer. About 15%-25% of patients with colorectal cancer have synchronous liver metastasis at the initial diagnosis. With the development of new evidence and concept of surgery, there is a improvement in the understanding of the surgical treatment, transformation treatment, criteria of surgical resectability and prognosis of patients with colorectal liver metastasis (CRLM). Based on latest progress, specialized multi-disciplinary team decides the best individualized treatment strategy. This paper reviews the current situation and progress of CRLM.肝脏转移是结直肠癌患者最主要的致死性原因之一，15%~25%的结直肠癌患者初诊时已发生同步肝转移。随着外科新证据、新理念的发展，对结直肠癌肝转移（CRLM）患者手术治疗、转化治疗以及手术可切除性和预后的判断标准等也有了新的认识。完善的多学科诊疗团队依据新证据，综合考虑多方面因素，制定适合患者的个性化治疗方案，避免不必要的手术并发症，改善患者生活质量，延长患者生存时间，这是CRLM的治疗目的。本文针对目前CRLM的的现状及研究进展进行了综述。.